Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling

被引:57
|
作者
Jenkins, Jean
Calzone, Kathleen A. [1 ]
Dimond, Eileen
Liewehr, David J.
Steinberg, Seth M.
Jourkiv, Oxana
Klein, Pam
Soballe, Peter W.
Prindiville, Sheila A.
Kirsch, Ilan R.
机构
[1] Natl Human Genome Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Genet Branch, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, Biostat & Data Management Sect, Bethesda, MD 20892 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[6] Amgen Inc, Seattle, WA USA
关键词
genetic testing; genetic counseling; BRCA1/BRCA2; result disclosure; risk communication;
D O I
10.1097/GIM.0b013e31812e6220
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. Methods: A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. Results: There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. Conclusions: These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [41] Medical management of individuals with a BRCA1 or BRCA2 variant of unknown significance genetic test result.
    Rashid, A
    Rosado, Z
    Hilsenbeck, S
    Brown, P
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S151 - S152
  • [42] A scoping review of parents' disclosure of BRCA1/2 genetic alteration test results to underage children
    de la Serna, Celia Diez de los Rios
    Dowling, Maura
    Mcnamara, Nichola
    Ivory, John D.
    Hanhauser, Yvonne
    Murphy, Meghan
    Dean, Marleah
    PATIENT EDUCATION AND COUNSELING, 2025, 131
  • [43] Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer
    A Brédart
    J L Kop
    A DePauw
    O Caron
    S Sultan
    D Leblond
    A Fajac
    B Buecher
    M Gauthier-Villars
    C Noguès
    C Flahault
    D Stoppa-Lyonnet
    S Dolbeault
    British Journal of Cancer, 2013, 108 : 1012 - 1020
  • [44] Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer
    Bredart, A.
    Kop, J. L.
    DePauw, A.
    Caron, O.
    Sultan, S.
    Leblond, D.
    Fajac, A.
    Buecher, B.
    Gauthier-Villars, M.
    Nogues, C.
    Flahault, C.
    Stoppa-Lyonnet, D.
    Dolbeault, S.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1012 - 1020
  • [45] Patients' resistance to risk information in genetic counseling for BRCA1/2
    Gurmankin, AD
    Domchek, S
    Stopfer, J
    Fels, C
    Armstrong, K
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) : 523 - 529
  • [46] BREAST CANCER PATIENTS' SATISFACTION WITH THE BRCA1/2 GENETIC COUNSELING
    Vadaparampil, Susan T.
    Quinn, Gwendolyn P.
    Miree, Cheryl A.
    Pickard, Jennifer
    Sutphen, Rebecca
    Jacobsen, Paul B.
    ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S210 - S210
  • [47] Non-presencial genetic counseling for BRCA1/2 families
    Carneiro, M.
    Simoes, C.
    Opiniao, A.
    Luis, A.
    Camara, J.
    Vidal, R.
    Parreira, J.
    Parreira, J.
    Rodrigues, P.
    Vaz, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S317 - S317
  • [48] BRCA1/2 haplotype analysis and genetic predisposition to sporadic ovarian carcinoma
    Frey, M. K.
    Bogomolniy, F.
    Dao, F.
    Siegel, C.
    Levine, D. A.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S95 - S96
  • [49] Patient-reported outcomes in a multicenter randomized study of in-person versus telephone disclosure of genetic test results for cancer susceptibility.
    Bradbury, Angela R.
    Patrick-Miller, Linda. J.
    Egleston, Brian L.
    Olopade, Olufunmilayo I.
    Hall, Michael J.
    Daly, Mary Beryl
    Fleisher, Linda
    Grana, Generosa
    Ganschow, Pamela
    Fetzer, Dominique
    Domchek, Susan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Extended follow-up in the COGENT study: A randomized study of in-person versus telephone disclosure of cancer genetic test results.
    Bradbury, Angela R.
    Patrick-Miller, Linda J.
    Egleston, Brian L.
    Domchek, Susan M.
    Olopade, Olufunmilayo I.
    Hall, Michael J.
    Daly, Mary Beryl
    Fleisher, Linda
    Grana, Generosa
    Ganschow, Pamela
    Fetzer, Dominique
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35